Clinical Trials Directory

Trials / Unknown

UnknownNCT00851292

The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing

The BIOPRES Trial; Transrectal BIOpsies of the PRostate: End Versus Side-firing

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
800 (estimated)
Sponsor
Amphia Hospital · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the difference in prostate cancer between two prostate biopsy techniques, namely end-firing and side-firing. These differ in the angle at which the prostate is biopsied.

Detailed description

Rationale: Research towards the efficacy of transrectal prostate biopsies has predominantly focused on the amount of biopsy cores. However, variation in the angle of entrance of the biopsy gun has been less studied. It is believed that obtaining biopsy cores by end firing will improve the efficacy, because of an improved sampling of the apical region. Objectives: To investigate the difference between side and end-firing in transrectal prostate needle biopsies in terms of qualitative and quantitative prostate cancer detection. Methods: From September 1st 2009 - September 1st 2012, all men with an initial prostate biopsy in a representative, Dutch, general hospital with six participating urologists and two residents will be subjected to a randomized controlled, single blind, single center, diagnostics trial. Men will be randomized for a biopsy using an end-firing or a side-firing probe. The primary endpoint is the prostate cancer detection rate; secondary endpoints are the number of cores invaded with prostate cancer, nomogram for indolent cancer-score, Gleason score, complications and biopsy length. Expected outcomes: We hypothesize that no differences between the biopsy techniques exist.

Conditions

Interventions

TypeNameDescription
DEVICETRUS probeend-firing and side-firing vary in the angle in which they sample the prostate

Timeline

Start date
2009-10-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2009-02-25
Last updated
2011-06-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00851292. Inclusion in this directory is not an endorsement.